Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer

Shi Jin,1,* Shoubo Cao,1,2,* Aleksei Grigorev,3,* Jianhua Li,4 Qingwei Meng,1 Chunyan Wang,1,2 Meiyan Feng,5 Jing Hu,1 Feng Jiang,3 Yan Yu1 1Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People’s Republic of China; 2Department of Medical Oncology, Linyi...

Full description

Bibliographic Details
Main Authors: Jin S, Cao S, Grigorev A, Li J, Meng Q, Wang C, Feng M, Hu J, Jiang F, Yu Y
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:Cancer Management and Research
Subjects:
lung cancer
cancer/testis antigens
immunotherapy
prognosis
profiling
Online Access:https://www.dovepress.com/establishment-of-cancertestis-antigen-profiling-based-on-clinicopathol-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/establishment-of-cancertestis-antigen-profiling-based-on-clinicopathol-peer-reviewed-article-CMAR

Similar Items